Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for CRMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 257.35M
March 31, 2026 178.74M
December 31, 2025 149.19M
September 30, 2025 55.72M
June 30, 2025 190.71M
March 31, 2025 77.50M
December 31, 2024 51.69M
September 30, 2024 46.03M
June 30, 2024 45.61M
March 31, 2024 58.63M
December 31, 2023 76.11M
September 30, 2023 86.67M
June 30, 2023 52.49M
March 31, 2023 55.73M
December 31, 2022 58.92M
September 30, 2022 59.11M
June 30, 2022 64.74M
March 31, 2022 61.82M
December 31, 2021 65.60M
September 30, 2021 72.10M
June 30, 2021 78.39M
March 31, 2021 81.31M
December 31, 2020 46.54M
September 30, 2020 37.22M
June 30, 2020 22.62M
Date Value
March 31, 2020 23.36M
December 31, 2019 28.51M
September 30, 2019 32.61M
June 30, 2019 26.56M
March 31, 2019 26.37M
December 31, 2018 17.80M
September 30, 2018 6.615M
June 30, 2018 4.874M
March 31, 2018 8.334M
December 31, 2017 12.16M
September 30, 2017 12.18M
June 30, 2017 18.99M
March 31, 2017 13.94M
December 31, 2016 20.34M
September 30, 2016 26.83M
June 30, 2016 28.78M
March 31, 2016 30.40M
December 31, 2015 35.56M
September 30, 2015 38.02M
June 30, 2015 37.62M
March 31, 2015 8.931M
December 31, 2014 4.340M
September 30, 2014 5.92M
June 30, 2014 7.652M
March 31, 2014 9.410M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Innoviva, Inc. 579.06M
Zevra Therapeutics, Inc. 221.57M
Filana Therapeutics, Inc. 82.68M
Eloxx Pharmaceuticals, Inc. 61.97M
Cannabis Global, Inc. 0.0116M